Rapid detection of Candida species in bronchoalveolar lavage fluid from patients with pulmonary symptoms

Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]
Hossein ZarrinfarRasoul Mohammadi

Abstract

Candida species, especially C. albicans, are commensals on human mucosal surfaces, but are increasingly becoming one of the important invasive pathogens as seen by a rise in its prevalence in immunocompromised patients and in antibiotic consumption. Thus, an accurate identification of Candida species in patients with pulmonary symptoms can provide important information for effective treatment. A total of 75 clinical isolates of Candida species were obtained from the bronchoalveolar lavage fluid of both immunocompromised and immunocompetent patients with pulmonary symptoms. Candida cultures were identified based on nuclear ribosomal Internal Transcribed Spacer (ITS1-ITS2 rDNA) sequence analysis by polymerase chain reaction-restriction fragment length polymorphisms (PCR-RFLP). Molecular identification indicated that the isolates belonged predominantly to C. albicans (52%), followed by C. tropicalis (24%), C. glabrata (14.7%), C. krusei (5.3%), C. parapsilosis (1.3%), C. kefyr (1.3%) and C. guilliermondii (1.3%). Given the increasing complexity of disease profiles and their management regimens in diverse patients, rapid and accurate identification of Candida species can lead to timely and appropriate antifungal therapy.

References

Dec 1, 1977·The American Journal of Medicine·H MasurD Armstrong
Apr 1, 1980·American Journal of Clinical Pathology·T E KiehnD Armstrong
Nov 1, 1995·Comprehensive Therapy·M G Cormican, M A Pfaller
Jan 5, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D P KontoyiannisI I Raad
Apr 6, 2002·American Journal of Respiratory and Critical Care Medicine·Jean Chastre, Jean-Yves Fagon
Aug 8, 2002·Oral Diseases·L P SamaranayakeP Wanzala
Jan 7, 2003·Infectious Disease Clinics of North America·Jose A Vazquez, Jack D Sobel
May 19, 2004·Intensive Care Medicine·Elie AzoulayJean-François Timsit
Aug 31, 2006·Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology·Hossein MirhendiHideyo Yamaguchi
Jun 10, 2011·Indian Journal of Medical Microbiology·S AgarwalP Bhalla

❮ Previous
Next ❯

Citations

Oct 28, 2017·Journal of Clinical Laboratory Analysis·Alireza EsmailzadehTanuka Sen
Sep 26, 2019·Journal of Medical Microbiology·Lingyue SunJin Yu
Apr 20, 2017·Pathogens and Disease·Kathryn M PendletonRobert P Dickson
Jun 12, 2018·BioMed Research International·Saeid Mahdavi OmranMojtaba Taghizadeh-Armaki
Dec 5, 2019·Antibiotics·Antonia Thassya Lucas Dos SantosHenrique Douglas Melo Coutinho

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage
biopsy
biopsies
PCR
electrophoresis

Software Mentioned

DNASIS

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.